Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity

被引:607
作者
Smyth, MJ [1 ]
Dunn, GP
Schreiber, RD
机构
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, E Melbourn, Vic 3002, Australia
[2] Washington Univ, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63130 USA
来源
ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY | 2006年 / 90卷
关键词
D O I
10.1016/S0065-2776(06)90001-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cellular transformation and tumor development result from an accumulation Of mutational and epigenetic changes that alter normal cell growth and survival pathways. For the last 100 years, there has been a vigorous debate (is to whether the unmanipulated immune system can detect and eliminate such altered host derived cells despite the fact that cancer cells frequently express either abnormal proteins or abnormal levels of normal cellular proteins that function as tumor antigens. In this review, toe discuss the current state of this argument and point out some of the recent key experiments demonstrating that immunity not only protects the host from cancer development (i.e., provides a cancer immunosurveillance but also can promote tumor growth, sometimes by generating more aggressive tumors. The terminology "cancer immunoediting" has been used to describe this dual host protective and tumor promoting action Of immunity, and herein we summarize the ever-increasing experimental and clinical data that support the validity of this concept.
引用
收藏
页码:1 / 50
页数:50
相关论文
共 279 条
  • [51] Onconeural antigens and the paraneoplastic neurologic disorders: At the intersection of cancer, immunity, and the brain
    Darnell, RB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) : 4529 - 4536
  • [52] REGRESSION OF SMALL-CELL LUNG-CARCINOMA IN PATIENTS WITH PARANEOPLASTIC NEURONAL ANTIBODIES
    DARNELL, RB
    DEANGELIS, LM
    [J]. LANCET, 1993, 341 (8836) : 21 - 22
  • [53] MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function
    Das, H
    Groh, V
    Kuijl, C
    Sugita, M
    Morita, CT
    Spies, T
    Bukowski, JF
    [J]. IMMUNITY, 2001, 15 (01) : 83 - 93
  • [54] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    Dave, SS
    Wright, G
    Tan, B
    Rosenwald, A
    Gascoyne, RD
    Chan, WC
    Fisher, RI
    Braziel, RM
    Rimsza, LM
    Grogan, TM
    Miller, TP
    LeBlanc, M
    Greiner, TC
    Weisenburger, DD
    Lynch, JC
    Vose, J
    Armitage, JO
    Smeland, EB
    Kvaloy, S
    Holte, H
    Delabie, J
    Connors, JM
    Lansdorp, PM
    Ouyang, Q
    Lister, TA
    Davies, AJ
    Norton, AJ
    Muller-Hermelink, HK
    Ott, G
    Campo, E
    Montserrat, E
    Wilson, WH
    Jaffe, ES
    Simon, R
    Yang, LM
    Powell, J
    Zhao, H
    Goldschmidt, N
    Chiorazzi, M
    Staudt, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) : 2159 - 2169
  • [55] Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions
    Davidson, WF
    Giese, T
    Fredrickson, TN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) : 1825 - 1838
  • [56] A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
    Dhodapkar, MV
    Geller, MD
    Chang, DH
    Shimizu, K
    Fujii, SI
    Dhodapkar, KM
    Krasovsky, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) : 1667 - 1676
  • [57] The intriguing role of polymorphonuclear neutrophils in antitumor reactions
    Di Carlo, E
    Forni, G
    Lollini, P
    Colombo, MP
    Modesti, A
    Musiani, P
    [J]. BLOOD, 2001, 97 (02) : 339 - 345
  • [58] Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
    Diefenbach, A
    Jamieson, AM
    Liu, SD
    Shastri, N
    Raulet, DH
    [J]. NATURE IMMUNOLOGY, 2000, 1 (02) : 119 - 126
  • [59] A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity
    Diefenbach, A
    Hsia, JK
    Hsiung, MYB
    Raulet, DH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (02) : 381 - 391
  • [60] Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
    Diefenbach, A
    Jensen, ER
    Jamieson, AM
    Raulet, DH
    [J]. NATURE, 2001, 413 (6852) : 165 - 171